Focus Partners Wealth
ABBV icon

Focus Partners Wealth’s AbbVie ABBV Stock Holding History

Focus Partners Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,500
Closed -$977K – 1900
2024
Q4 		$977K Hold
5,500
– – ﹤0.01% 1067
2024
Q3 		$1.09M Buy
+5,500
New +$1.03M ﹤0.01% 923

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Focus Partners Wealth's ABBV Position: Q1 2026 in Review

Focus Partners Wealth reduced its AbbVie (ABBV) stake by 2% in Q1 2026, selling an estimated $3.97M and leaving 894,467 shares worth $194M. The position accounts for 0.22% of the portfolio, ranked #103.

Focus Partners Wealth first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $208M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Focus Partners Wealth held 894,467 shares of AbbVie worth $194M as of Q1 2026.
  • Focus Partners Wealth sold 17,893 AbbVie shares in Q1 2026, an estimated $3.97M.
  • AbbVie made up 0.22% of Focus Partners Wealth's portfolio in Q1 2026, its #103 holding.
  • Focus Partners Wealth first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • Focus Partners Wealth's AbbVie position peaked at $208M in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.